1. Anderzhanova, E., Rayevsky, K. S., Saransaari, P., and Oja, S. S. (2003). Effect of sulpyride on the amphetamine-induced changes in extracellular dopamine, DOPAC, and hydroxyl radical generation in the rat striatum. Neurochem. Res. 28:1241–1248.
2. Andrews, R. J. (2001). Neuroprotection for the new millenium. Matchmaking pharmacology and technology. Ann. N.Y. Acad. Sci. 939:114–125.
3. Green, A. R., Ashwood, T., Odergren, T., and Jackson, D. M. (2003). Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059. Pharmacol. Ther. 100:195–214.
4. Gu, Z., Kaul, M., Yan, B., Kridel, S. J., Strongin, I. J., Liddington, R. C., and Lipton, S. A. (2002). S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death. Science 297:1196–1190.
5. Hall, E. D., Andrus, P. K., Smith, S. L., Fleck, T. J., Scherch, H. M., Lutzke, B. S., Sawada, G. A., Althaus, J. S., Vonvoigtlander, P. F., Padbury, G. E., Larson, P. G., Palmer, J. R., and Bundy, G. L. (1997). Pyrrolopyrimidines: Novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models. J. Pharmacol. Exp. Ther. 281:895–904.